PureTech Health (PRTC) Other Non-Current Assets (2019 - 2025)
PureTech Health (PRTC) reported Other Non-Current Assets of -$12.7 million for Q4 2025, down 150.84% year-over-year from $25.0 million in Q4 2024, and down 2770.95% quarter-over-quarter from $475000.0 in Q2 2025.
PureTech Health (PRTC) Other Non-Current Assets (2019 - 2025) Analysis & Trends
PureTech Health (PRTC) has 7 years of Other Non-Current Assets data on file, last reported at -$12.7 million in Q4 2025.
- Other Non-Current Assets for Q4 2025 came in at -$12.7 million, down 150.84% year-over-year; the trailing twelve-month figure through Dec 2025 was -$12.7 million (down 150.84% YoY), and the FY2025 annual result was -$12.7 million, down 150.84% from the prior year.
- Other Non-Current Assets eased to -$12.7 million in Q4 2025 per PRTC's latest filing, from $475000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $64.6 million in Q4 2022 and troughed at -$12.7 million in Q4 2025.
- A 5-year average of $22.0 million and a median of $25.0 million in 2024 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets surged 37.31% in 2022, then sank 150.84% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $47.0 million in 2021, then jumped by 37.31% to $64.6 million in 2022, then tumbled by 55.19% to $28.9 million in 2023, then retreated by 13.75% to $25.0 million in 2024, then slumped by 150.84% to -$12.7 million in 2025.
- Business Quant data shows PRTC's Other Non-Current Assets at -$12.7 million in Q4 2025, $475000.0 in Q2 2025, and $25.0 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | -12.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12.69 Mn |
| Jun 30, 2025 | 475,000.00 |
| Dec 31, 2024 | 24.95 Mn |
| Jun 30, 2024 | 878,000.00 |
| Dec 31, 2023 | 28.93 Mn |
| Dec 31, 2022 | 64.56 Mn |
| Dec 31, 2021 | 47.02 Mn |
| Dec 31, 2020 | 45.48 Mn |
| Dec 31, 2019 | 2.12 Mn |